Use Able AI chat for product recommendations

Recombinant Human Periostin protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg4564



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human Periostin protein Asn22-Gln836 (Accession# Q15063-1) with a rabbit IgG Fc tag at the C-terminus.
GeneID 10631
Accession Q15063-1
PredictedSize 117.2 kDa
SDS-PAGE 120-150 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Periostin (POSTN, PN), originally named as osteoblast-specific factor 2 (OSF-2), is a 90-kDa secreted protein which is now classified as a matricellular protein. It is present in a wide variety of normal adult tissues and fetal tissues, and has a role in bone, tooth and heart development and function. Studies show that periostin is overexpressed in a broad range of human cancer types, including lung, ovary, breast and colon cancers. Recent evidence reveals that periostin is expressed by fibroblasts in the normal tissue and in the stroma of the primary tumour, and it is required to allow cancer stem cell maintenance.

References:

1. Gillan, Lindsay et al. Cancer research vol. 62,18 (2002): 5358-64. 2. Morra, Laura, and Holger Moch. Virchows Archiv : an international journal of pathology vol. 459,5 (2011): 465-75. 3. Duchamp de Lageneste, Oriane, and Céline Colnot. Advances in experimental medicine and biology vol. 1132 (2019): 49-61.

||
New chat

Able

正在加载,请稍候...